The Newborn and Child Health Commodities subgroup hosted a webinar to present the updated RMNCH forecasting supplement to assist program managers, service providers, and technical experts to conduct quantification of priority medicines for child health. This document was first published in 2016 and the USAID Medicines, Technologies and Pharmaceutical Services Program (MTaPS) has updated it to include new products and recommendations from WHO. The webinar gave a brief overview of the guide, highlighted its application for child health and provided a country perspective of its usefulness.
Increasing access to and appropriate use of reproductive, maternal, newborn, and child health (RMNCH) medical products could save the lives of more than 6 million women and children annually. A major component of access is availability, which requires accurate and timely quantification of supply requirements. Systematic and rigorous quantification of RMNCH medical products is often overlooked, yet accurate forecasting is essential for budgeting, resource mobilization, and planning for procurement and supply chain operations of RMNCH medical products.
- Jane Briggs, Senior Principal Technical Advisor and MNCH Portfolio Lead, USAID MTaPS, Management Sciences for Health
- Andualem Oumer, Principal Technical Advisor for Supply Chain and Pharmacovigilance, USAID MTaPS, Management Sciences for Health
- Lillian Gu, FASP Team, USAID Global Health Supply Chain Program, Procurement and Supply Management
- Antonia Ibeme, Forecasting and Supply Chain Manager, USAID Global Health Supply Chain Program, Procurement and Supply Management Nigeria
- Patrick Gaparayi, Supply Chain Manager, UNICEF Supply Division
Access the recording and presentation below.